THROMBOXAN-REZEPTOR-ANTAGONISTEN
European patent · EP3865472 · In force
Register entry
- Publication number
- EP3865472
- Application number
- EP20212296
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 13, 2016
- Published
- Aug 18, 2021
- Granted
- Jun 12, 2024
- Protection ends at the latest
- Jun 12, 2036
- Next annual fee due
- Jun 30, 2027
- IPC classes
- C07C 311/58 (2006.01)A61K 31/64 (2006.01)A61P 3/10 (2006.01)A61P 7/02 (2006.01)A61P 9/00 (2006.01)A61P 9/10 (2006.01)A61P 9/12 (2006.01)A61P 11/00 (2006.01)A61P 11/06 (2006.01)A61P 13/08 (2006.01)A61P 13/12 (2006.01)A61P 29/00 (2006.01)A61P 35/00 (2006.01)A61P 43/00 (2006.01)
- Priority
- US 201562180317 P 16.06.2015
- Divided from
- EP16739541
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.06.2026 → 30.06.2027
Published in Swissreg on 01.07.2026
- Jul 1, 2025
Next annual fee due on
- Next annual fee due on
- 30.06.2025 → 30.06.2026
Published in Swissreg on 01.07.2025
- Apr 23, 2025
Change
Published in Swissreg on 23.04.2025
- Sep 3, 2024
Next annual fee due on
- Next annual fee due on
- 30.06.2024 → 30.06.2025
Published in Swissreg on 03.09.2024
- Jul 15, 2024
Agent entered
- Representative
- Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex
Published in Swissreg on 15.07.2024
- Jun 12, 2024
Granted
Published in Swissreg on 12.06.2024
Parties
Inventor
REID, Helen
Dublin 13, IE
KINSELLA, B. Therese
Dublin, Blackrock Co., IE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.